Milano, Italy

Milan 20157

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Macular Edema (DME), Parkinson Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• Open-label Trial in Parkinson's Disease (PD) — Completed